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Abstract
Background: Enteric antimicrobial peptides secreted from Paneth cells, including α-defensins (in
mice named cryptdins), are key effector molecules of innate immunity in the small intestine. The
importance of Paneth cells α-defensins emerged from studies of enteric bacterial infection in
genetically modified mice, as well as from recent studies linking reduced levels of these α-defensins
to Crohn's disease localized to the ileum. However, analysis of expression of Paneth cell α-
defensins is incomplete. We therefore performed a comprehensive evaluation of the distribution
of antimicrobial molecules along the mouse small intestinal tract to identify potential variations in
regional expression.
Results: In conventionally reared mice, the repertoire of Paneth cell antimicrobials differs between
duodenum and ileum. In contrast to the uniform expression of most Paneth cell antimicrobials,
both cryptdin 4 and cryptdin-related sequences (CRS) 4C peptides were expressed at progressively
increasing amounts (101- and 104-fold, respectively) comparing duodenum and ileum. In tissues
other than the small intestine, expression of CRS peptides was noted in thymus and caecum. Most
Paneth cell products were also produced in the small intestine of germ-free mice at levels similar
to those in controls, however CRS4C and RegIIIγ had reduced levels in the former (3- and 8-fold,
respectively). No significant changes in expression levels of Paneth cell antimicrobial peptides was
observed after oral challenge with either Salmonella enterica serovar typhimurium or Listeria
monocytogenes, supporting current notions on the constitutive nature of this defensive system.
Conclusion: The repertoire of antimicrobial peptides changes along the small intestinal tract, and
a subset of these molecules are up-regulated upon colonization, but not in response to enteric
bacterial pathogens. The changes detected upon colonization suggest that Paneth cell antimicrobial
peptides may play an important role in commensal microbial homeostasis, in addition to their
proposed role in protection against infection. In addition, the differential expression of CRS4C
along the small intestine suggests mechanisms of regulation that are distinct from other Paneth cell
derived antimicrobial peptides.
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Background
The gastrointestinal epithelium is continuously exposed
to high numbers of bacteria, including the resident micro-
biota as well as to foreign bacteria. Despite this high bac-
terial exposure, infections are rare, which suggests highly
efficient mechanisms both to protect the host and to
maintain a host-microbe balance. Protection in the small
intestine is attributed, in part, to a mucosal barrier com-
posed of mucins and secreted antimicrobial components
from Paneth cells. Paneth cells are highly differentiated,
long-lived [1] secretory cells that are located at the base of
crypts of Liberkühn. Paneth cell granules are released by
neural stimulation or in response to luminal bacteria or
bacterial compounds [2]. Many important antibacterial
components, such as α-defensins (cryptdins in mice), lys-
ozyme, phospholipase A2 and the C-type lectin RegIIIγ are
produced at high levels and stored in Paneth cell granules
[3,4]. Humans have only two α-defensins [5] whereas
mice have many cryptdins and cryptdin-related sequence
(CRS) peptides expressed in their Paneth cells [3,6]. Most
of the mouse cryptdins belong to the highly similar cryp-
tdin 1 group, with the exceptions being cryptdins 4 and 5
[3]. The cell specific regulation of Paneth cell α-defensins
has partly been unravelled with the recent identification
of the transcription factor TCF-4 being a key protein [7,8].
The CRS peptide family in mice was initially described at
the mRNA level based on its similarities to the pro-
sequence of cryptdins [6,9,10], but the processed peptide
shares no similarities with cryptdins. Mature CRS peptides
are divided into two groups; CRS1C containing 11
cysteines and CRS4C with 9 (10) cysteines [9,11]. We
have shown previously that CRS4C peptides have antimi-
crobial activity against both Gram-positive and Gram-
negative bacteria [11]. The antimicrobial spectra of these
peptides are broadened by the fact that they form both
homo- and heterodimers, which have distinct but over-
lapping antimicrobial activities [11].
The importance of the small intestinal antimicrobial pep-
tides has been highlighted in both human and mice.
Recently, a reduction of Paneth cell α-defensins was
implicated as a key contributor to the innate immune dys-
function seen in Crohn's ileitis [12]. In addition, mice
with deficient processing of cryptdins are more sensitive
to oral infection by Salmonella enterica serovar typhimu-
rium [13], whereas transgenic mice with one additional
human  α-defensin expressed in Paneth cells are more
resistant to Salmonella [14]. Together, these findings sup-
port the hypothesis that Paneth cell defensins are key
effector molecules of innate immunity in the intestinal
tract, but many questions remain to be solved regarding
their expression and regulation.
The data presented here demonstrates that Paneth cells
along the longitudinal axis of the small intestine are het-
erogeneous with respect to their expression of antimicro-
bial peptides. The most significant heterogeneity was
detected for the CRS peptide CRS4C, with a 104-fold
increased expression in the ileum compared to the duode-
num. Consistent with previous studies, the expression of
Paneth cell antimicrobials varied little in response to bac-
terial pathogens, suggesting that this defense system is an
ever-present arm of innate immunity. An evaluation of
the levels in germ-free versus conventionally housed mice
revealed that the relative distribution of some Paneth cell
antimicrobials was influenced by bacterial colonization.
Together these data provide a foundation to help in the
design and interpretation of mouse models of enteric
infection and inflammation.
Results
Variant CRS sequences in FVB mice
Previous studies identified variant CRS transcript forms
when comparing different mouse strains [6,9,11,15]. We
therefore sought to investigate the transcripts derived
from the small intestine of FVB mice using an anchored
PCR strategy (for primers see Table 1). We identified ten
different deduced CRS peptide sequences from 21
sequenced clones (Table 2). The sequences were com-
pared from the amino terminus of the mature peptide
(here defined as LQD) through to the stop codon. Four
clones encoded CRS1C peptides and six encoded CRS4C
peptides, Table 2. Both previously annotated sequences
and novel sequences were found. In addition, we noted
that three clones coded for the same active peptides, but
had sequence variations in the 3'-non-coding region (data
not shown). This suggests that the same active peptide can
be encoded by several gene paralogs.
Both specific forward and reverse primers, as well as an
anchored PCR strategy were used to screen for potential
CRS4C-4 and CRS4C-6 transcripts in the small intestine
(Table 1), but no sequences were detected in the FVB
mice.
CRS4C is stored in Paneth cell granules
We generated antibodies against CRS4C-3a in order to
localize CRS peptides using immunohistochemistry. This
antibody also recognizes synthetic CRS4C-1a, but the pre-
immune sera did not (data not shown). As shown in Fig-
ure 1, granules in Paneth cells from the ileum stained
positive for CRS4C. Thus, CRS4C peptides are stored in
granules similar to other characterized Paneth cell antimi-
crobials.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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Paneth cell antimicrobial differences in regional and 
developmental expression patterns
In order to compare the mRNA levels of Paneth cell
derived antimicrobial molecules we used a quantitative
real-time reverse transcriptase PCR (qRT-PCR) assay that
measures the number of transcripts derived from 10 ng of
RNA (primer sequences are found in Table 1). The nor-
malization to the amount of total RNA renders compari-
son between different RNA sources and gene products
possible. Measurements were made from segments (6 cm)
of the duodenum, jejunum, and ileum tissue from each of
four different adult FVB mice (from two different litters)
in order to evaluate the spatial distribution of antimicro-
bial peptide expression. Consistently high expression of
CRS1C was observed throughout the small intestine (Fig-
ure 2A). In contrast, the expression of CRS4C is region-
specific, being low in duodenum and 12,000 times higher
in ileum (Figure 2A).
We next quantified expression of other Paneth cell derived
products using qRT-PCR (Figure 2A). The assay for crypt-
din 1 also detects mRNA transcripts from cryptdin 2 and
3, but from here on is referred to as "cryptdin 1". Cryptdin
1, Paneth cell-lysozyme (pLys) and secretory phospholi-
pase A2 (sPLA2) expression remained unchanged when
comparing duodenum and ileum. Cryptdin 4 expression
increased 16-fold from duodenum to ileum. The results
for cryptdin 4 are in accordance with previous data
[16,17], where the transcripts were measured using stand-
ard RT-PCR and immunohistochemistry, which makes
quantitative comparisons with our results difficult. When
comparing the mRNA levels of the different antimicrobial
peptides in ileum, CRS4C had a five-fold higher expres-
sion than cryptdin 1 followed by CRS1C > cryptdin 4 >
pLys and sPLA2 (Figure 2B). For the same analysis in the
duodenum, the levels were, in decreasing order; cryptdin
1 > CRS1C > pLys > sPLA2 > cryptdin 4 ≈ CRS4C.
The protein levels of CRS4C and cryptdin 2 were deter-
mined in the duodenum, jejunum and ileum of two
BALB/c mice by Western blot analysis (reported as micro-
gram of peptide per gram of tissue, Figure 2C). The levels
of CRS4C in the duodenum were below detection level, in
jejunum were 39 μg/g and in the ileum were 54 μg/g. The
level of cryptdin 2 was 74 μg/g for duodenum, 93 μg/g
from jejunum and 66 μg/g from ileum.
Antimicrobial peptide levels in duodenum and ileum
from 14- and 18 day old mice were compared to that of
adult levels (Figure 3). The mRNA for CRS1C and cryptdin
1 in duodenum was 30- and 8-fold higher,  respectively,
in adult compared to day 14 tissue (Figure 3A). CRS4C
and cryptdin 4 did not display such increase in duode-
num, and remained at a constant low level during devel-
opment. In the ileum, however, CRS4C and cryptdin 4,
displayed higher expression in  adult compared to day 14
tissue, which was similar to cryptdin 1 and CRS1C (Figure
3B).
Table 1: Primers used for cloning of CRS peptides and for qRT-PCR assays
Primers used for cloning of CRS peptides
Product Sense Antisense
CRS 5'aaggctctg(c/g)tcttcaagat3'
5'tg(c/g)tcttcaagatg(t/c)agccc3'
5'ccatcctaatacgactcactatagggc3'
CRS4C-4 5'gtgagtgctggactcagcc3' 5'gattgcatttgcagctcggg3'
CRS4C-6 5'cctaggaaagcctccccagt3' 5'ttttgtcatgcaattgcacc3'
Primers used for qRT-PCR assays
CRS1C 5'caccacccaagctccaaatacacag3' 5'atcgtgaggaccaaaagcaaatgg3'
CRS4C 5'gcatggaatctgggtcaagataac3' 5'agaaggaagagcaatcaaggctaag3'
Crypt1 5'tcaagaggctgcaaaggaagagaac3' 5'tggtctccatgttcagcgacagc3'
Crypt4 5'gctgtgtctatctcctttggaggc3' 5'cgtattccacaagtcccacgaac3'
mLys 5'ggctggctactatggagtcagcctg3' 5'gcattcacagctcttggggttttg3'
pLys 5'gccaaggtctaacaatcgttgtgagttg3' 5'cagtcagccagcttgacaccacg3'
sPLA2 5'aggattcccccaagatgccac3' 5'cagccgtttctgacaggagttctgg3'
TCF-4 5'cggctcactccacagctcaaag3' 5'cgagaatctggttgatggctgc3'
NOD2 5'cgacatctcccacagagttgtaatcc3' 5'ggcacctgaagttgacattttgc3'
MMP7 5'ttcaagagggttagttgggggactg3' 5'ttgtcaaagtgagcatctccgcc3'
Reg3g 5'cctcaggacatcttgtgtctgtgctc3' 5'tccacctctgttgggttcatagcc3'
Crypt4 C57BL/6 5'ccaggggaagatgaccaggctg3' 5'tgcagcgacgatttctacaaaggc3'
Note that two gene-specific sense primers were used to clone CRS cDNA.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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Table 2: Deduced amino acid sequence of putative mature CRS peptides
Deduced amino acid sequence mRNA accession number Mouse strains Reference
CRS1C sequences
Novel CRS1C
CRS1C-4 LQDAAQRRFPWCRKCRVCQKCQVCQ
KCPVCPTCPQCPKQPLCEERQNKTAIT
TQAPNTQHKGC
EU760893 FVB this report
CRS1C-5 LQDVAQRRFPWCRKCRVCQKCQVCQ
KCPVCPTCPLCPKQPLCEERQNKTAITT
QAPNTQHKGC
EU760894 FVB this report
CRS1C-6 LQDVAQRRFPWCRKCPVCQKCQVCQ
KCPVCPTCPQCPKLPLCKERQNKSAITT
QAPNTQHKGC
EU760895 FVB this report
Annotated CRS1C
CRS1C LQDVAQRRFPWCRKCRVCQKCQVCQ
KCPVCPTCPQCPKQPLCEERQNKTAIT
TQAPNTQHKGC
M33226 FVB, Outbred Swiss albino [9]
CRS1C-1 LQDVAQRRFPWCRKCRVCQKCEVCQ
KCPVCPTCPQCPKQPLCKERQNKTAIT
TQAPNTHHKGC
XM_001006437 C57BL/6* [15]
CRS1C-2 LQDVAQRRFLWCRKCPVCQKCQVCQ
KCPVCPTCPQCPKQPLCEERQNKTAIT
TQAPNTQHKGC
AY761183 C57BL/6 [15]
CRS1C-3 LQYVAQRRFPWCRKCPVCQKCQVCQ
KCPVCPTCPQCPKLPLCKERQNKSAITT
QAPNTQHKGC
AY761184 C57BL/6 [15]
CRS4C sequences
Novel CRS4C-1/2/3
CRS4C-3f LQDAALGWGRRCPWCPPCPNCRRCP
RCPTCPSCNCNPK
EU760896 FVB this report
Annotated CRS4C-1/2/3
CRS4C-1a/e/f/h/j LQDAALGWGRRCPQCPRCPSCPSCPR
CPRCPRCKCNPK
M33227 FVB, Outbred Swiss albino, C3H/
HeN, 129/SVJ
[9]
CRS4C-1b/d/g/i LQDAAVGWGRRCPQCPRCPSCPSCPR
CPRCPRCKCNPK
AJ564861 FVB, 129/SVJ, C3H/HeN [6]
CRS4C-2/c/d LQDAALGWGRRCPRCPPCPRCSWCPR
CPTCPRCNCNPK
NM_007848 FVB, 129/SVJ, C3H/HeN [6]
CRS4C-2b LQDAALGWGRRCPRCPPCPRCSWCPG
CPTCPRCNCNPK
AJ564871 C3H/HeN [11]
CRS4C-3/a/b/e LQDAALGWGRRCPRCPPCPNCRRCPR
CPTCPSCNCNPK
AJ564873 FVB, 129/SVJ, C3H/HeN [6]
CRS4C-3c LQDAALGWSRRCPRCPPCPNCRRCPR
CPTCPSCNCNPK
AJ564876 C3H/HeN [11]
CRS4C-3d LQDAALGWGRRCPRCPPCPNCRRCPR
CPTCPRCNCNPK
AJ564877 FVB, C3H/HeN [11]
Related CRS
CRS4C-4 LQDAAVGMARPCPPCPSCPSCPWCPM
CPRCPSCKCNPK
NM_007845 129/SVJ [6]
CRS4C-5 LQDAAAIRRARRCPPCPSCLSCPWCPRC
LRCPMCKCNPK
NM_007846 129/SVJ* [6]
CRS4C-6 LQVSGLGKPPQCPKCPVCSKCPQCP
QCPQCPGCPRCNCMTK
AY761185 C57BL/6 [15]
Underlined: Variations in amino acid sequence within the group of CRS1C and CRS4C, respectively. One example of mRNA accession number 
only. * = predicted from genome sequence, no mRNA found.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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Antimicrobial peptide expression in other tissues
We isolated RNA and measured transcript numbers from
different tissues of FVB mice in order to identify potential
tissues, apart from small intestine, where CRS and other
antimicrobial molecules might be expressed. CRS and
cryptdins were also detected in caecum and thymus (Table
3). The expression of CRS4C mRNA in both caecum and
thymus was lower than in jejunum but higher than in
duodenum. None of the cryptdins or CRS peptides were
detected at appreciable levels in other tissues. Notably, the
expression of cryptdins and CRS was not detected in other
immune related sites such as bone marrow or spleen. The
level of CRS protein expression was below the detection
limit for Western blot (less than 3 μg/g tissue) and immu-
nohistochemistry in caecum and thymus (data not
shown).
Impact of germ-free condition and bacterial infection on 
levels of Paneth cell antimicrobials
Germ-free NMRI/KI mice were used to assess the role of
the resident microbiota on CRS peptide expression. RNA
was isolated from whole small intestine of germ-free as
well as conventional mice and transcript copy numbers
were compared using qRT-PCR (Figure 4). The expression
levels represent two categories, less than three-fold higher
expression (CRS1C, cryptdin 1, cryptdin 4, NOD2,
MMP7, mLys and pLys) and more than three-fold higher
levels (CRS4C, sPLA2 and RegIIIγ). The higher expression
of CRS4C, sPLA2 and RegIIIγ in conventionally reared
mice could not be explained by TCF-4 expression since the
levels of TCF-4 remained unchanged. This demonstrates
Immunohistochemical localization of CRS4C in ileal part of  the small intestine Figure 1
Immunohistochemical localization of CRS4C in ileal 
part of the small intestine. A) CRS4C (green) stains 
Paneth cell granules in crypts of Liberkühn of a C3H/HeN 
mouse. A higher magnification of the base of the crypt is 
shown in (B). Hoechst staining (blue) was used to visualize 
the nucleus.
Antimicrobial peptide expression along the mouse small  intestine Figure 2
Antimicrobial peptide expression along the mouse 
small intestine. A) CRS, cryptdins, pLys, and sPLA2 mRNA 
expression in small intestine measured by qRT-PCR. Abso-
lute mRNA copy numbers were determined in the duode-
num, jejunum, and ileum. The "x" numbers denote relative 
copy numbers between ileum and duodenum. The results are 
based on four FVB mice, and are given as mean and range. B) 
Comparative distributions in duodenum and ileum. Of note is 
that duodenum has a total of 2 × 106 copies of Paneth cell 
products, while ileum has 18 × 106 copies (area of the smaller 
duodenal and the ileal pies are proportional to total mRNA 
copy counts of analyzed antimicrobials). Colours denote indi-
vidual Paneth cell products. C) Western blot of extracts 
from two individual BALB/c mice was analyzed using antibod-
ies to CRS4C-3 and cryptdin 2. Duod = duodenum, Jej = 
jenunum and Ile = ileum.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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that the normal flora influences the expression of a subset
of Paneth cell peptides and that transcription factors other
than TCF-4 likely contribute to this effect.
Mice were intragastrically infected with S. typhimurium
serovar typhimurium and whole small intestine was ana-
lyzed at different time points up to eight hours post infec-
tion. With qRT-PCR we did not observe any significant
changes in transcript levels (Figure 5A). Three days after
oral infection with L. monocytogenes, small intestine was
analyzed. No changes in cryptdin 2 or CRS4C were
detected using Western blot analysis (Figure 5B).
CRS peptide levels vary in different mouse strains
A comparison of the CRS repertoire identified here in FVB
mice to the previously reported collection of enteric
CRS4C sequences in C3H/HeN mice [11] suggested a sig-
nificant strain-to-strain variation, which we evaluated fur-
ther. Total small intestine (Table 4) or small intestine
divided up into 3 equally long pieces (Table 5) were ana-
lysed for cryptdin and CRS content in different mouse
strains using qRT-PCR. NMRI/KI, C3H/HeN and FVB
strains share a similar expression profile, while C57BL/6
clearly diverges. When comparing cryptdin 4 expression, it
is clear that C57BL/6, which harbours a unique cryptdin 4
variant, had the highest level with on average 30-fold
higher expression (6 × 106 copies vs. average of 2 × 105
copies). Cryptdin 4 from C57BL/6 also increased from
duodenum to ileum (Table 5). C57BL/6 mice do not
express CRS peptides detectable with the primers used for
CRS4C. Within the other strains of mice the levels of the
different products do not vary more than three-fold.
Discussion
The small intestine is a heterogeneous tissue with longitu-
dinal differences in nutrient adsorption capacity and in
resident microbiota. The bias in colonization of the termi-
nal small intestine depends on host factors rather than
initial bacterial input [18]. Here we show that Paneth cell
derived antimicrobial peptides differ along the length of
the small intestine, and may be one factor that contributes
to colonization. Other host factors that may influence col-
onization include pH, peristalsis and glycans [19]. Based
on human association studies [12] and transgenic mice
[13,14], it is clear that antimicrobial peptides in the small
intestine play important functions both in man and
mouse. The characteristic localization in the small intes-
tine of celiac and Crohn's diseases to the duodenum and
ileum, respectively, might be linked to differences in
innate functions and regional expression/release of
defensins.
Two families of defensins/defensin-like antibacterial mol-
ecules are expressed in Paneth cells of mouse small intes-
tine: cryptdins and CRS4C, whereas information is
lacking on the antibacterial properties of CRS1C. Crypt-
dins, with the exception of cryptdin 4 [16,17], and CRS1C
are equally expressed along the small intestine, and repre-
sent "class I" defensins. CRS4C and cryptdin 4, represent-
ing "class II" defensins, are shown to be more restricted to
the ileal region of the small intestine. Together with other
antimicrobial factors this likely creates a distinct antimi-
crobial milieu in the ileum as compared to duodenum.
Similarly, the human enteric α-defensin 5 and 6 also
increase along the small intestinal axis [20] without a con-
comitant increase in Paneth cell numbers [21]. Patil and
co-workers [15] showed that also rat antimicrobial pep-
tide genes expressed in small intestine corresponded to
two groups with one expressed in equal numbers along
the intestinal axis while the other group increased.
The two proteins with most prominent differences in
expression between germ-free and colonized mice, CRS4C
(this study) and RegIIIγ [4] both have important longitu-
dinal differences in intestinal expression. Expression of
sPLA2 also varied between germ-free and colonized con-
ditions. Cryptdins are constitutively expressed, even
under germ-free conditions ([22] and this study). While
this study was under review, Inoue et al published a
mRNA expression of CRS and cryptdins during small intesti- nal development in A) duodenum, B) ileum Figure 3
mRNA expression of CRS and cryptdins during small 
intestinal development in A) duodenum, B) ileum. 
Data is based on small intestinal tissue from three FVB mice 
in each group. Absolute mRNA copy numbers were deter-
mined in the duodenum and ileum at post-natal days 14 and 
18 (preweaning) and adult mice. Means and range are 
depicted. The "x" numbers denote relative copy numbers 
measured by qRT-PCR between adult and 14 day old mice.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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detailed study on the developmental expression of crypt-
din 1–6 in germ-free and conventional BALB/c mice,
showing enhanced expression in conventional mice of all
cryptdins, especially after weaning [23]. The bacteria do
not appear to influence the activation of cryptdin peptides
since germ-free mice produce mature cryptdins [22]. Thus,
much of the peptide repertoire is formed independently
of colonization, although we in general detected Paneth
cell products at lower levels in germ-free mice, possibly
correlating with decreased Paneth cell numbers [24]. We
did not observe any altered synthesis of CRS peptides (or
cryptdins) in adult mice after oral challenge with the path-
ogenic bacteria Salmonella or Listeria. Cryptdin expres-
sion has been reported to be repressed in FVB mice after
wild type Salmonella infection with maximum decrease
after 18 hours [25]. Our results are generated in C3H/HeN
mice and analysed for up to 8 hours. The models are
therefore not directly comparable. It is possible that a
response to invasive pathogens can occur at the processing
or granule release level rather than increased synthesis,
which may already be at high capacity.
Table 3: Distribution of antimicrobial peptide expression in different mouse tissues measured by qRT-PCR
CRS1C CRS4C Crypt1 Crypt4 sPLA2 pLys mLys GAPDH
tongue * * * * * 318 7,090 67,100
trachea * 359 * * * 13,000 317,000 22,100
esophagus * * * * * 438 29,900 101,000
cardiac stomach * 882 * * * * 4,730 16,000
body stomach * 1,570 * * * * 3,040 43,200
pyloric stomach 166 111 1,530 * 1,920 * 5,640 64,600
caecum 210 240,000 29,100 2,630 10,100 3,830 49,400 162,000
ascending colon * 262 151 * 2,730 339 34,800 142,000
transcending colon * * * * 12,600 287 25,200 135,000
descending colon * * * * 9,680 400 34,000 191,000
rectum * * * * 7,010 445 89,100 72,300
thymus 1,950 19,100 622 224 * 1,820 265,000 48,300
lung * 101 * * * 245,000 1,050,000 29,800
bone marrow * * * * * * 1,080,000 89,000
skin * 625 * * * * 542 *
liver * 205 * * * * 24,800 50,100
salivary gland * * * * * 144 13,600 31,300
heart * * * * * 152 21,400 202,000
kidney * * * * * * 5,610 190,000
spleen 115 393 * * * 179 114,000 38,200
Results are based on pooled tissues from 4–20 FVB mice. Caecum and thymus showed highest expression of cryptdins and CRS peptides. * = <100 
copies/10 ng RNA. Three significant digits displayed.
Innate defense molecules expressed in small intestine of germ-free and conventional mice Figure 4
Innate defense molecules expressed in small intestine of germ-free and conventional mice. A) CRS and cryptdins, 
B) other mRNA transcripts detected in whole small intestine. Means and range are depicted. Numbers denotes relative copy 
numbers between small intestine of germ-free and conventional NMRI/KI mice. Four mice in each group. * denotes P < 0,03.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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Paneth cell linage emerges in mouse foetal small intestine
with characteristic morphology of Paneth cells (including
granules) on post-natal day 7 (P7). The lineage then
expands greatly during the period of days P14–P21
[26,27]. Here we show that the expression levels of CRS
and other antimicrobial peptides are detectable at day 14,
but to a different degree for individual products. The dif-
ferentiation of intestinal stem cells and commitment to
the Paneth cell lineage is dependent on several transcrip-
tion factors (reviewed in [28]). The transcription factor
TCF-4 plays a major role in both early differentiation and
in the maturation of Paneth cells [8] following Wnt/β-cat-
enin mediated signalling [29]. TCF-4 also regulates the
expression of class I defensins, including cryptdin 1 [7,8],
CRS1C [30], as well as α-defensin 5 and 6 in humans
[7,8]. We find it more probable, however, that additional/
other transcription factors, with a gradually increasing
expression pattern throughout the small intestine regu-
lates class II defensins such as CRS4C. One putative tran-
scription factor could be the newly described intestine-
specific homeobox; Isx [31]. Isx has a selective expression
in the small intestine with an increase from duodenum to
ileum. Two other putative transcription factors are ME1
and PPARβ [32,33].
Cryptdin and CRS genes in mice are located adjacently on
chromosome 8, in a region known to have undergone sig-
nificant changes through evolution [15]. The precise
number of genes is not clear, but a large number of differ-
ent CRS mRNA sequences has been identified in various
mouse strains, including 129/SVJ (8), C3H/HeN (17) and
in FVB mice (13) ([6,11], this study) that generates strik-
ing differences in expression pattern. For example, CRS4C
is the dominant peptide expressed by C3H/HeN, NMRI/
KI and FVB mice but C57BL/6 mice lack this peptide fam-
ily and perhaps compensate by expressing higher
amounts of the C57BL/6 specific cryptdin 4. The variation
in peptide repertoire may very well be responsible for a
difference in microbiota between mice. This idea is
strengthened by experiments with transgenic mice in
which Paneth cell expression of a human counterpart of
cryptdins, α-defensin 5, changed the composition of the
flora [12]. If variations in peptide-mediated defense
between mouse strains confer differences in intestinal
Whole small intestinal expression of cryptdins and CRS peptides after infection Figure 5
Whole small intestinal expression of cryptdins and CRS peptides after infection. A) CRS and cryptdins measured by 
qRT-PCR after Salmonella infection of C3H/HeN mice at different time points. B) CRS peptides and cryptdins measured by 
Western blot from four individual BALB/c after three days of Listeria infection (denoted by triangles). Four mice receiving PBS 
were used for comparison (squares).
Table 4: Differences in mRNA expression of CRS and cryptdins in small intestine of different mouse strains
C57BL/6, N = 2 NMRI/KI, N = 4 C3H/HeN, N = 4
CRS1C 2.0 × 106 7.5 × 105 1.1 × 106
CRS4C Not present 3.0 × 107 1.4 × 106
Crypt1 4.4 × 106 5.6 × 106 6.9 × 106
Crypt4 Not present 2.3 × 105 1.9 × 105
Crypt4 C57BL/6 5.8 × 106 Not present Not present
Average mRNA levels in whole small intestine of adult C57BL/6, NMRI/KI and C3H/HeN mice measured by qRT-PCR. N = number of mice. 
Numbers denotes mRNA copy numbers per 10 ng RNA. Note that C57BL/6 mice lack CRS4C-1 to 3 and cryptdin 4 and display a unique cryptdin 
4 variant.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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microbiota, then it is an open question to whether this
can be one of the explanations for the difference in sus-
ceptibility to oral infection.
Conclusion
The repertoire of mouse Paneth cell antimicrobial mole-
cules shows significant regional variation between duode-
num and ileum. Expression of some of these effector
molecules was up-regulated in conventional versus germ-
free mice, but the majority did not change. Together, these
observations indicate that multiple regulatory pathways
coordinate the expression of Paneth cell antimicrobial
molecules. The overall repertoire may play an important
role in local bacteria-host homeostasis, in addition to
their proposed role in protection against infection.
Methods
Mouse strains and tissues
C3H/HeN, NMRI/KI, FVB, BALB/c and C57BL/6 adult
mice were housed under standard pathogen-free condi-
tions. Adult mice were defined as 7 weeks for Figure 1, 4–
6 weeks for Figure 2A–B and 3A–B, 3 weeks for Figure 2C
and 5B, 8–12 weeks for Figure 4 and 6–12 weeks for Fig-
ure 5A. Germ-free NMRI/KI mice were housed in sterile
environment. The designation "duodenum" represents
the proximal 1/3 of the small intestine, whereas "jeju-
num" and "ileum" were the medial 1/3 and the distal 1/3,
respectively. In qRT-PCR assays of small intestine of FVB
mice, six cm of the most proximal, most distal and the
medial part were used. Eight centimetres of proximal and
eight centimetres of distal small intestine were excised
from 14 and 18 day old FVB mice. Large intestine was
divided into three equally sized pieces and named ascend-
ing-trans- and descending colon. All tissues used for RNA
isolation except for small intestine were collected and
pooled from several animals. Small intestine, caecum and
thymus from C3H/HeN mice were used for Western blot
and immunohistochemistry.
Mouse infections
Three female C3H/HeN mice were intragastrically
infected with 8 × 108 Salmonella enterica serovar typhimu-
rium strain ATCC 14028 and whole small intestine was
removed at 30 min, 2 h or 8 h post infection. Control mice
received phosphate buffered saline. Three BALB/c female
mice were orally challenged with 109  Listeria monocy-
togenes  type 1 clinical isolate and small intestine was
removed after three days. Control mice received phos-
phate buffered saline, and livers and spleens were homog-
enized and plated to access infection status.
Antibodies and peptides
Synthetic CRS4C-3 (LGWGRRCPRCPPCPN-
CRRCPRCPTCPSCNCNPK) and cryptdin 2 (LRDLVCY-
CRTRGCKRRERMNGTCRKGHLMYTLCCR) peptides
were used to raise antibodies in rabbits (Innovagen, Lund,
Sweden). The antibodies were purified using protein G.
The synthetic peptides were used as standards for Western
blot.
RNA preparation and reverse transcriptase PCR
Tissue was snap frozen in liquid nitrogen or alternatively
placed in RNAlater (Ambion, Austin, TX, USA) for storage
and RNA was subsequently isolated with guanidine iso-
thiocyanate buffer followed by a 5.7 M cesium chloride
cushion [34]. Five micrograms of RNA were used with
Oligo-(dT)12–18 for reverse-transcriptase PCR with GIBCO
BRL superscript first strand synthesis system (Grand
Island, NY, USA) in accordance to the manufacturer's rec-
ommendations. The polyA specific adaptor primer 5'-
ttctagaattcagcggccgc(t)30NN-3' was used for reverse tran-
scriptase PCR of CRS1C and CRS4C. The cDNA was puri-
fied with Qiaquick PCR purification kit (Qiagen, Hilden,
Germany).
Cloning of CRS and other antimicrobial peptide products
Cloning of products was performed with standard proce-
dures [20]. Briefly, 10–100 ng of cDNA was amplified
with gene-specific primers with Roche FastStart Taq DNA
Polymerase (Roche Applied Science, Mannheim, Ger-
many). The product was cloned into pBluescript II and
transfected into DH5α competent cells (both from Invit-
rogen, Carlsbad, CA, USA). Plasmid was isolated,
Table 5: Regional differences in mRNA expression of CRS and 
cryptdins in small intestine of different mouse strains
C57BL/6 FVB
CRS1C D = 1.8 × 106 D = 7.6 × 105
J = 2.6 × 106 J = 4.3 × 105
I = 2.5 × 106 I = 1.1 × 105
CRS4C Not present D = 1.2 × 105
J = 1.2 × 107
I = 2.5 × 107
Crypt1 D = 2.2 × 106 D = 3.3 × 106
J = 3.0 × 106 J = 3.2 × 106
I = 5.6 × 106 I = 2.2 × 106
Crypt4 Not present D = 1.6 × 104
J = 1.1 × 105
I = 2.5 × 105
Crypt4 C57BL/6 D = 1.4 × 105 Not present
J = 4.7 × 106
I = 8.7 × 106
Expression of CRS and cryptdin in different parts of the small intestine 
measured by qRT-PCR. Tissues pooled from three mice. D = 
duodenum, J = jejunum, I = ileum. Numbers denotes mRNA copy 
numbers per 10 ng RNA. Note that C57BL/6 mice lack CRS4C-1 to 3 
and cryptdin 4 and display a unique cryptdin 4 variant.BMC Immunology 2008, 9:37 http://www.biomedcentral.com/1471-2172/9/37
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sequenced, quantified and diluted in series of 10-fold
dilutions in 0.02 g/l torula yeast RNA (Sigma-Aldrich, St
Louis, MO, USA). The procedures for cloning of CRS
sequences were the same as above except for two different
forward primers and an adaptor specific reverse primer in
the initial step (Table 1).
Quantitative reverse transcriptase PCR
Roche Lightcycler with Lightcycler-FastStart DNA Master
SYBR Green I kit (Roche) was used to make standard series
of each cloned product with its matched primers, Table 1.
The standard was used to measure gene copy number of
the unknown sample derived from 10 ng of RNA as previ-
ously described [20]. Samples were measured in dupli-
cates. The CRS4C assay did not cross-react with CRS1C
and vice versa. Gene copy numbers below 100 copies are
reported as absent.
Immunohistochemistry
Ileum from a C3H/HeN mouse was fixed with formalin
(Histolab, Göteborg, Sweden). After deparafinization,
slides were submerged in boiling antigen retrieval buffer
(1 mM sodium citrate, 1 mM citric acid in water pH 6) for
two minutes. Cells were permeabilized with 0.1% triton-
X100 before incubation with CRS4C antibody. FITC con-
jugated AffiniPure F(ab')2 fragment of donkey anti-rabbit
IgG (H+L) antibodies were used for detection (Jackson,
West Grove, PA, USA). Samples were washed three times
in phosphate buffered saline (PBS) in between each incu-
bation step. Hoechst 33258 (Sigma-Aldrich) staining was
used to visualize the nucleus.
Protein extraction from mouse tissue
Tissues were ground in liquid nitrogen and extracted (one
hour, +4°C) in final volumes of 60% acetonitrile and 1%
triflouroacetic acid. The homogenate was clarified with
centrifugation, the supernatant was lyophilised, and re-
dissolved in the same volume of 20% ethanol as the
ground tissue weight, as described in [22].
Western blot
Protein extracts were mixed with 4 M urea (final concen-
tration), NuPAGE LDS Sample buffer (Invitrogen) and
10% β-mercaptoethanol before heating at 100°C. Iodoa-
cetamide (final concentration 50 mM) was added and
extract originating from 2.5 μg tissue was loaded into each
lane. Proteins were separated using 1.0 mm 4–12%
NuPAGE Bis-Tris gels in NuPAGE MES SDS running buffer
and blotted onto polyvinylidene difluoride filters (all
from Invitrogen). The filters were blocked in 2% dried
milk in PBS with 0,1% Tween (PBST). Incubation with
antigen-specific antibodies and horseradish peroxidase
(HRP)-conjugated anti-rabbit antibody were in 1%
bovine serum albumin in PBST. Bound antibody was
detected by chemiluminescence (SuperSignal West Dura,
Pierce Biotechnology, Rockford, IL, USA). Densitometric
readings of the blots were accessed with Image gauge v4
(Fujifilm, Stamford, CT, USA). Three different dilutions of
synthetic CRS4C-3 and cryptdin 2 peptide were analysed
simultaneously and protein bands were quantified.
Statistical analyses
Error bars in graphs represent range. Significance of 95%
was evaluated with Mann-Whitney two tailed test.
Abbreviations
qRT-PCR: quantitative real-time reverse transcriptase-
polymerase chain reaction; CRS: cryptdin-related
sequences; Crypt1: cryptdin 1 family of sequences;
Crypt4: cryptdin 4; mLys: myeloid-specific lysozyme;
pLys: Paneth cell specific lysozyme; sPLA2: secretory phos-
pholipase A2 type IIa; GAPDH: glyceraldehyde-3-phos-
phate dehydrogenase; TCF-4: transcription factor 7-like 2,
also known as TCF7L2; NOD2: nucleotide-binding oli-
gomerization domain containing 2; RegIIIγ: regenerating
islet-derived 3 gamma; MMP7: matrix metallopeptidase
7/matrilysin.
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